Background: Suicidal behavior is a worldwide health problem. Tryptophan hydroxylase (TPH) is a rate limiting enzyme in the biosynthesis of serotonergic neurotransmission. TPH-1 and TPH-2 genes encode for TPH isoforms and have been implicated as candidate genes for suicidal behavior. The aim of this study was to evaluate the association between the genetic variants of the TPH-1 (rs21102 and 1607395) and TPH-2 (rs4290270, rs7305115 and rs1007023) genes and suicidal behavior in a Mexican population. Methods: We conducted a case-control study including 200 cases with suicide attempt and 263 controls. Patients were evaluated by a trained psychiatrist or clinical psychologists. Five polymorphisms were genotyped and assessed for allele, genotype and haplotype association with suicide attempt. Results: The rs7305115 polymorphism of the TPH-2 gene was associated with suicidal behavior in a Mexican population in genotype (χ 2 = 6.02, df = 2, p = 0.04) and allele (OR = 1.39, 95%IC = 1.06-1.81, p = 0.01) frequencies. The THP-2 haplotypes GTA (χ 2 = 5.68, p = 0.01) and ATT (χ 2 = 5.0, p = 0.02) were associated with risk for suicide attempt. Conclusion: Our results provide evidence for an association between the rs7305115 polymorphism of the TPH-2 gene and suicidal behavior in a Mexican population. However, more studies are necessary to replicate these results using larger samples.
Introduction
Suicide is a critical problem among the general population; it is classified among the leading causes of death and injuries around the world [1] . It is estimated that by the year 2020, the number of deaths by suicide will increase 50% with an annual rate of 1.53 million subjects [2] [3] [4] . Nowadays, there is available evidence from genetic analyses based on family, adoption and twin studies that explore the genetics of suicidal behavior. From these studies the comparison of monozygotic or identical twins with dizygotic or two egged twins has been the focus of the search for positive evidence concerning a genetic component of this disease [5, 6] .
Until now, most of the genetic studies and meta-analyses have involved serotonin related genes because serotonin levels and those of its metabolites are thought to play an important role in suicidal behavior (SB) [7] [8] [9] [10] [11] . For example, low levels of 5-HIAA, the metabolite of serotonin, in CSF (cerebrospinal fluid) have been found in both (ASBERG 1976 ) and in high lethality attempted suicides (MAN AND MALONE 1997). Therefore, several studies have investigated the involvement of the tryptophan hydroxylase (TPH) gene in genetic susceptibility to suicidal behavior [12] [13] [14] . The principal reason for testing an association between the TPH gene and suicidal behavior is that this enzyme is a rate limiting factor in the biosynthesis of 5-HT neurotransmission and plays a key role in regulating availability, turn over and function of serotonin [15, 16] . TPH has two isoforms: TPH-1, expressed in peripheral tissues, and TPH-2, most recently discovered and expressed predominantly in the brain [17] [18] [19] . The TPH-1 gene is located on chromosome 11p15, spans 29 Kb and has 11 exons, whereas the TPH-2 gene is located on chromosome 12q21.1, has 11 exons and covers a region of about 93.5 Kb (checked in gene cards on 22 March 2015) . Both genes present several polymorphisms; the most common variants for TPH-2 are (1) a change in the base 1125 of A N T (rs4290270) in exon 9, (2) the rs7305115 polymorphism at 1077 on exon 7 and (3) the rs1007023 variant which in the role intron (boundary) exhibits a G N T substitution. With regard to TPH-1, the most important variants are (1) rs211102 located also in an intron with a variation A N G with no amino acid change and (2) rs1607395 in an intron as well, with the variation C N T [20] [21] [22] [23] . Various studies have suggested that the polymorphisms affecting TPH-1 and TPH-2 gene expression may result in the alteration of physiological processes related to 5-hidroxytryptamine (5-HT) [24] [25] [26] [27] .
For example, Liu and et al. found differences in the distribution of the TPH1 gene variant (A218C) when elderly suicide victims and controls were compared [28] . To support the importance of the study of TPH, Perround et al. found significantly higher TPH2 mRNA levels in suicide victims than in controls [29] . However, the information obtained in these studies provides no conclusive results [30] [31] [32] .
Therefore, we decided to analyze the association between genetic variants of TPH-1 and TPH-2 genes and suicidal behavior in a case-control study in a Mexican population.
PICO question
In Mexicans adults with attempted suicide do TPH1 (rs211102, rs1607395) and TPH2 (rs7305115, rs1007023, rs4290270) gene variants exhibit significant differences when compared with those of healthy subjects without suicidal behavior?
Methods

Sample
The sample included 463 subjects. The comparison group was formed by 263 subjects, all of them unrelated to suicide attempters, physically healthy during the medical evaluation, un-manifested psychiatric problems, and without a history of suicide attempts (all assessed during brief interviews performed by clinical psychiatrists); they were recruited randomly when they attended the Blood Donor Center in the municipality of Comalcalco in the state of Tabasco, as described in a previous publication [33] . The sociodemographic characteristics are shown in Table 1 .
The cases group comprised 200 patients. From these, 169 patients were consecutively recruited from the outpatient service of the General Hospital of Comalcalco in the state of Tabasco, Mexico. These patients had attempted suicide between January 2011 and February 2012. In addition, 31 patients were recruited from the Academic Multidisciplinary Division of Comalcalco (DAMC) at the Juarez Autonomous University of Tabasco (UJAT). To reduce ethnic variation and stratification effects, only Mexican subjects descending from Mexican parents and grandparents were included in the study. Also, all subjects came solely from the municipality of Comalcalco. No differences with respect to demographic, psychiatric and medical factors were evaluated between the two participant centers.
Clinical evaluation
The patient group had attempted suicide between January 2013 and December 2013; the range of the attempts covered a history from 1 to 5. Each patient was diagnosed based on the Structured Clinical Interview for DSM-IV Axis in Spanish, in which disorders pertaining to Axis I, II and II were considered. Trained psychiatrists or clinical psychologists (with a master's degree or a higher educational level) evaluated all the patients. We defined suicide attempt as a self-harm behavior with at least some intent to end one's life. The psychiatric diagnosis is shown in Table 2 . Subjects with self-injury behavior, undetermined suicide attempt, or ideation of suicide were excluded from the study based on the Scale for Suicide Ideation in the Spanish version. Also, subjects were excluded when they presented a history of concomitant medical or neurological illness and intellectual disability.
On the other hand, all healthy subjects were interviewed using systematic bases to obtain a detailed medical and psychiatric history to exclude subjects who had relatives with a lifetime history of mental disorder or suicidal behavior.
Ethics statement
All subjects signed an informed consent to participate in the study after they were given verbal and written explanations of the research objectives; they did not receive any economical remuneration. This study complied with the principles convened in the Helsinki Declaration. In addition, this study was approved by the DAMC-UJAT Ethics and Research Committee (UJAT-DAMC-2012-02) and also fulfilled the guidelines of STREGA, an extension of the STROBE statement [34] . (Supplementary material).
Genotype assays
Peripheral blood samples were taken from all subjects; DNA was extracted using the Wizard Genomic DNA Purification Kit (Promega). All the genotypes studied were determined using a polymerase chain reaction (PCR) end-point method. The polymorphisms studied (rs4290270, rs211102, rs1607395, rs7305115 and rs1007023) are available from TaqMan SNP Genotyping Assay made to order by Applied Biosystems. We followed the manufacturers' genotyping protocol. All genotyping were performed using a patient-blind outcome design. As a quality control in our genotyping analyses we used random blind duplicates that were checked for genotype concordance (the concordance rate was 100%).
We selected 3 SNPs (single nucleotide polymorphisms) of the TPH-2 gene. The rs7305115 variant was considered because a positive association with suicidal behavior was shown in the literature [35, 36] . The rs4290270 polymorphism not only exhibits a positive association, but has also been suggested to participate in TPH-2 alternative splicing [37] .
Statistical analysis
The Hardy-Weinberg equilibrium was assayed using the test for deviation from the Hardy-Weinberg equilibrium and test for association, both freely available from http://ihg.gsf. de/cgi-bin/hw/hwa1.pl. The chi-squared test was used to compare genotype and allele frequencies between groups. We used the Haploview 4.2 program to calculate the linkage disequilibrium of the markers and haplotype association [38] . The power of association was analyzed with Quanto 1.2 software. As an example, in the case of rs4290270, the power of the analysis was 0.05 [minor allele frequency = 0.423; genetic odds ratio (R G ) = 1.0; overall disease risk in the general population (P 0 ) = 0.04]. The level of significance was set at 0.05. To evaluate multiple comparisons, the significance level for Bonferroni's test was established at p = 0.016 (0.05/3).
Results
In the present study a total of 200 unrelated suicide attempters (82 males and 118 females) were recruited; mean age was 27.17 (SD 9.56) years old; range 14-57 years of age. Only 9 subjects under 18 years of age were included. The comparison group consisted of 263 subjects (96 males and 167 females); mean age was 33.72 (SD 13.24) years old; range 14-73 years of age. 12 subjects under 18 years old were included. The Hardy-Weinberg equilibrium was measured in all genotyped individuals. For the TPH-1 gene, the group with suicidal behavior satisfied the Hardy-Weinberg equilibrium (p N 0.05) for the three polymorphisms (rs7305115, 4290270 and rs1007023). For the control group, rs1007023 did not satisfy the Hardy-Weinberg equilibrium, therefore, this polymorphism was excluded from the study. For the THP-1 analysis, both remaining SNPs satisfied the Hardy-Weinberg equilibrium in all cases and controls.
The linkage-disequilibrium evaluated in controls and suicide attempt groups for variants rs7305115 and rs4290270 of THP-2 are shown in Fig. 1 . We also measured the linkage-disequilibrium for TPH-1 which was r 2 = 1.0 (Supplementary material 1) . Table 3 shows genotype and allele frequencies of TPH-1 and TPH-2 genes in cases (n = 200) and controls (n = 263). A positive association was observed between rs7305115 and suicide attempt. We observed major frequencies for the AA genotype (χ 2 = 6.02, df = 2, p = 0.04) and A allele (OR = 1.39, 95%IC = 1.06-1.81, p = 0.01) in the cases group.
Next, we performed the haplotype analysis. For TPH-2 we found significant differences in the frequency distribution of two haplotypes (AT, GA) between cases and controls (p b 0.05). The AT haplotype was found as a protective haplotype against suicide attempt (χ 2 = 4.36, p = 0.03), whereas GA (χ 2 = 5.68, p = 0.01) was associated with higher risk for suicide attempt (Table 4) . After a correction for multiple testing was made, only haplotype GA remained statistically significant. In the case of TPH-1 no significant differences were observed.
Discussion
In the present study, we analyzed the possible association of TPH1 and TPH-2 genes variants with suicidal behavior in a Mexican population. We have already published a meta-analysis analyzing the association between TPH1 and TPH2 and suicidal behavior [9] . However, to our knowledge, the present report is the first that shows the relationship between TPH1 and TPH2 gene variants and suicidal behavior in a case-control association study in this region of the globe. For these variants, a haplotype analysis was performed.
The genetic analyses of the present study did not show an association between TPH1 and suicidal behavior by allele or genotype in the sample; however, a positive association was observed between allele A of rs7305115 of the TPH-2 gene and suicide attempt in the Mexican population. Our results are in Table 3 Genotypes, allele counts and frequency distributions for rs211102 and rs1607395 of the TPH-1 gene and rs4290270, rs7305115 and 1007023 of the TPH-2 gene in suicide attempters and control group in a Mexican population. agreement with several studies that have indicated a possible association between various TPH-2 polymorphisms (including rs7305115) with suicidal behavior and others psychiatric disorders [18, 39, 40] . In contrast, other studies did not find any association between TPH-2 variants and suicidality [26, 29, 41] . Nevertheless, we suggest that in Mexican suicide attempters, the TPH-2 rs7305115 SNP is a genetic risk for this psychiatric problem. When the analysis of haplotype was performed, the GA group of TPH2 variants showed a risk factor for suicidal behavior. However, at the moment these interpretations of positive outcomes are only speculative and need to be replicated, given that the role of the TPH-2 gene in suicidal behavior remains controversial. A more recent meta-analysis reported a lack of association between TPH-2 and suicidal behavior [9] ; however, the polymorphism included in the present study was not analyzed. In addition to the possibility of false/negatives, there are several potential reasons for the apparent discrepancy of the results found in this study. First, related reports have studied different ethnic groups; most of the published studies have been conducted in Caucasian [4, 39, 42, 43] and Asian [10, 24, 28, 40, 41] populations. To our knowledge, this work brings the first data on the TPH-1 gene in Mexican suicide attempters. Another factor influencing the results may be the gender of the sample; our study did not present data of gender composition as in other reports [1, 22] .
Other limitations may be the following: (1) we only evaluated rs211102 and rs1607395 for TPH-1 and rs4290270 and rs7305115 for TPH-2; more variants of both genes should be examined for suicidal behavior in future studies. Furthermore, this study does not explain the mechanism by which serotonin may influence suicidal behavior with respect to the different TPH-1 and TPH-2 SNPs. To elucidate this mechanism could help to understand the neurobiology of suicidal behavior and may reveal potential targets to prevent and treat patients suffering from this psychiatric problem. Another limitation is sample size, the sample in this study may be too small to detect the effect of TPH-1 and TPH-2 polymorphisms on suicide attempters, so it is important to replicate this study in other Mexican populations using larger samples.
Conclusions
In conclusion, we suggest that the rs7305115 polymorphism of the TPH-2 gene may exhibit an association with suicide attempt in a Mexican population. On the other hand, no association was observed between TPH-1 variants and suicide attempt. However, further studies are necessary to gain more insight into the association of TPH-1 and TPH-2 gene variants with suicidal behavior.
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